Cenci, Tonia
 Distribuzione geografica
Continente #
NA - Nord America 363
EU - Europa 64
AS - Asia 14
Totale 441
Nazione #
US - Stati Uniti d'America 362
IT - Italia 32
DE - Germania 8
VN - Vietnam 8
CZ - Repubblica Ceca 5
NL - Olanda 4
PL - Polonia 4
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
OM - Oman 2
BY - Bielorussia 1
CA - Canada 1
CN - Cina 1
FR - Francia 1
GB - Regno Unito 1
IE - Irlanda 1
JP - Giappone 1
MK - Macedonia 1
PT - Portogallo 1
RO - Romania 1
UA - Ucraina 1
Totale 441
Città #
Fairfield 50
Ashburn 44
Santa Cruz 42
Houston 29
Seattle 29
Woodbridge 23
Buffalo 14
Wilmington 13
Cambridge 12
Milan 12
Cattolica 11
Dong Ket 8
Los Angeles 6
Ann Arbor 5
Columbus 5
Redmond 4
San Diego 4
Warsaw 4
Boardman 3
Dallas 3
Santa Maria 3
Amsterdam 2
Bremen 2
Las Vegas 2
Saint Petersburg 2
Anaheim 1
Auburn 1
Bolzano 1
Bucharest 1
Busto Arsizio 1
Catania 1
Cheyenne 1
Chicago 1
Clearwater 1
Council Bluffs 1
Dublin 1
Frankfurt am Main 1
Johnson City 1
Lake Forest 1
Lexington 1
Milpitas 1
Minsk 1
Niagara Falls 1
Phoenix 1
Porto 1
Provo 1
Riva 1
Salò 1
Santa Clara 1
Sunnyvale 1
Wuhan 1
Yellow Springs 1
Ōtsu 1
Totale 360
Nome #
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents, file e309db6d-ba32-0599-e053-3705fe0a55db 150
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors, file e309db6e-3667-0599-e053-3705fe0a55db 120
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases, file e309db6d-fc77-0599-e053-3705fe0a55db 68
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation, file e309db6e-de1b-0599-e053-3705fe0a55db 56
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents, file e309db6e-9739-0599-e053-3705fe0a55db 38
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2, file e309db6d-5a66-0599-e053-3705fe0a55db 6
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma, file 379a8c4f-a9fd-4207-bc99-5c3bc652128a 4
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response, file e309db6d-5e33-0599-e053-3705fe0a55db 3
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis, file e309db6d-7eec-0599-e053-3705fe0a55db 2
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group, file cc37b4cd-bb20-4dd4-b8d5-87c0c66d7b91 1
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis, file e132a75b-5a1c-4d0e-8abe-c2d65d17bd08 1
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin, file e309db6d-3822-0599-e053-3705fe0a55db 1
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)), file e309db6d-3823-0599-e053-3705fe0a55db 1
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis, file e309db6d-621a-0599-e053-3705fe0a55db 1
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis, file e309db6d-8aee-0599-e053-3705fe0a55db 1
PDGFRA-mutant syndrome, file e309db6e-b183-0599-e053-3705fe0a55db 1
Totale 454
Categoria #
all - tutte 1.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 8 6
2019/202070 5 5 10 22 3 6 3 3 4 3 2 4
2020/202198 5 10 42 0 11 1 7 1 6 3 5 7
2021/2022121 16 4 1 3 12 9 1 3 5 12 37 18
2022/202393 1 3 33 23 3 7 5 2 3 5 8 0
2023/202441 1 5 7 0 6 3 2 1 4 3 9 0
Totale 454